【Objective】The research aims to reveal the effects of controlled-release urea(CRU) application in successive years on double-cropping rice yield, nitrogen use efficiency (NUE), and ammonia (NH3) volatilization loss, and to lay a theoretical basis and develop a new method for reducing nitrogen losses in paddy field while stabilizing grain yield. 【Method】There were six treatments including zero-N (CK), urea (U) and four CRU levels (CRU1, CRU2, CRU3, CRU4, 0, 10%, 20% and 30% nitrogen reduction of CRU) in cultivars Zhongzao 39 for early rice and Taiyou 390 for late rice. Ammonia volatilization were measured by using continuous air flow enclosure method, as well as grain yield and N content.【Result】NH3 volatilization after basal fertilization and fertilizer application for tillering (U, CRU) peaked within 1-2 d, 2-4 d, lasting 8-9 days in early-rice season; peaked within 2-3 d and 3-4 d, lasting for 6-7 days for late-rice season. U application generated the highest total NH3 volatilization loss (rate) of 47.2 kg/hm2 (26.4%), and 61.9 kg/hm2 (28.7%), with grain yields of 5.5 t/hm2 and 6.2 t/hm2, and NUE of 23.0% and 20.0% for early- and late-rice season, respectively; Total NH3 volatilization loss (rate) of CRU treatments in early and late rice seasons were 22.8-32.3 kg/hm2 (14.6%-16.5%), and 30.4-42.1 kg/hm2 (15.9%-17.6%), with grain yields 5.8-6.3 t/hm2 and 6.6-7.5 t/hm2, and NUE 34.3%-40.5% and 33.8%-39.2% for early- and late-rice seasons, respectively; And CRU1 treatment reduced total NH3 volatilization loss by 40.9% and 38.3%, increased grain yield by 14.9% and 20.9%, NUE by 75.6% and 96.0% for early- and late-season rice than those of U treatment. Total NH3 volatilization loss and grain yield for early-, late-season and annual rice in CRU treatments had significant linear relationship with N application rate, namely increased with the rising N application rate. 【Conclusion】Application of CRU significantly reduced NH3 volatilization loss, and increased grain yield and NUE in double-cropping rice system, especially in CRU1 treatment.